What are the emerging things that are on your mind of concerns, both contractual as well as cyber program, as you limited or involved in that?

Yeah, absolutely.

I mean, I think three things come to mind when it comes to the biotech pharma space.

One is obviously protecting your data and your intellectual property.

I think a lot of the breaches that we see in the biotech space are sometimes aimed at actually stealing intellectual property, not just getting some data so that we can go find some emails to send people, that kind of stuff, steal some social security numbers.

A lot of it is focused around actual corporate espionage.

And so I think that's something that we have to keep in mind.

use aggressive offense or, uh, you know, I,